Literature DB >> 6449994

Changes in charge density of heparan sulfate isolated from cancerous human liver tissue.

N Nakamura, J Kojima.   

Abstract

Heparan sulfate fractions were isolated from three normal human livers and three cancerous human liver tissues, and their polyanionic properties were examined using electrophoresis, sequential partition fractionation, and chemical analyses. More than 60% of total glycosaminoglycans from normal human liver and about 30% from cancerous liver tissue were found to be heparan sulfate from their resistance to exhaustive digestion with chondroitinase ABC and their susceptibility to nitrous acid treatment. The heparan sulfate isolated from cancerous liver tissue afforded a lower sulfate/uronic acid molar ratio (0.58 to 0.65) than did normal human liver heparan sulfate (0.76 to 0.80). Also, the former showed lower electrophoretic mobility in 0.1 M HCl and a different partition fractionation profile in comparison with the latter. These differences in charge density of the macromolecule were not detected on the chondroitin sulfate and/or dermatan sulfate fractions isolated from normal human liver and cancerous liver tissue.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6449994

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

Review 1.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Effect of heparin and liver heparan sulphate on interaction of HepG2-derived transcription factors and their cis-acting elements: altered potential of hepatocellular carcinoma heparan sulphate.

Authors:  J Dudás; G Ramadori; T Knittel; K Neubauer; D Raddatz; K Egedy; I Kovalszky
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

Review 3.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

Review 4.  Heparan sulfate in the nucleus and its control of cellular functions.

Authors:  Mark D Stewart; Ralph D Sanderson
Journal:  Matrix Biol       Date:  2013-12-03       Impact factor: 11.583

Review 5.  The dual role of the glycosaminoglycan chondroitin-6-sulfate in the development, progression and metastasis of cancer.

Authors:  Adam Pudełko; Grzegorz Wisowski; Krystyna Olczyk; Ewa Maria Koźma
Journal:  FEBS J       Date:  2019-02-05       Impact factor: 5.542

6.  Expression of glycosaminoglycans in cirrhotic liver and hepatocellular carcinoma-a pilot study including etiology.

Authors:  Gábor Tóth; Domonkos Pál; Simon Sugár; Ilona Kovalszky; Katalin Dezső; Gitta Schlosser; László Drahos; Lilla Turiák
Journal:  Anal Bioanal Chem       Date:  2022-03-28       Impact factor: 4.478

7.  Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival.

Authors:  Gábor Tóth; Simon Sugár; Domonkos Pál; Kata Dorina Fügedi; László Drahos; Gitta Schlosser; Csilla Oláh; Henning Reis; Ilona Kovalszky; Tibor Szarvas; Lilla Turiák
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

8.  Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface.

Authors:  R V Iozzo
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

9.  The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface.

Authors:  H J Garrigues; M W Lark; S Lara; I Hellström; K E Hellström; T N Wight
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.